Aflac Incorporated (NYSE:AFL) Shares Sold by Thoroughbred Financial Services LLC

Thoroughbred Financial Services LLC cut its stake in Aflac Incorporated (NYSE:AFL) by 9.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,623 shares of the financial services provider’s stock after selling 752 shares during the period. Thoroughbred Financial Services LLC’s holdings in Aflac were worth $788,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Whipplewood Advisors LLC purchased a new stake in shares of Aflac during the 4th quarter valued at $26,000. BankPlus Trust Department purchased a new stake in Aflac during the fourth quarter valued at about $34,000. Curio Wealth LLC purchased a new position in shares of Aflac in the 4th quarter worth about $36,000. Raelipskie Partnership acquired a new position in shares of Aflac in the 3rd quarter valued at about $38,000. Finally, OFI Invest Asset Management acquired a new stake in Aflac during the 4th quarter worth approximately $38,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Aflac Price Performance

AFL opened at $101.94 on Friday. The firm has a market cap of $55.64 billion, a price-to-earnings ratio of 10.62, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The company’s 50-day moving average price is $106.95 and its 200 day moving average price is $107.70. Aflac Incorporated has a fifty-two week low of $79.31 and a fifty-two week high of $115.50. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, sell-side analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.

Analysts Set New Price Targets

AFL has been the subject of a number of analyst reports. Morgan Stanley upped their price target on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Piper Sandler boosted their price target on Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research note on Wednesday. JPMorgan Chase & Co. raised their price objective on Aflac from $94.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Finally, Keefe, Bruyette & Woods decreased their price target on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research report on Wednesday, February 12th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $104.29.

Insiders Place Their Bets

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.